18 Cathie Wood Beam Therapeutics Trades
Cathie Wood's position in Beam Therapeutics is currently worth $158 Million. That's 1.42% of their equity portfolio (18th largest holding). The investor owns 8.43% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares eleven more times and sold shares on six occasions. The investor's estimated purchase price is $561 Million, resulting in a loss of 72%.
Avg closing price
Price range
Increased shares by 20.0% (+1.41 Million shares)
Q1 2025
Avg closing price
$26.26
Price range
$19.53
-
$34.09
Increased shares by 8.2% (+537 Thousand shares)
Q4 2024
Avg closing price
$25.65
Price range
$21.55
-
$30.35
Sold 14.4% shares (-1.1 Million shares)
Q3 2024
Avg closing price
$25.81
Price range
$22.57
-
$33.14
Sold 6.8% shares (-556 Thousand shares)
Q2 2024
Avg closing price
$24.56
Price range
$21.22
-
$32.66
Sold 12.9% shares (-1.21 Million shares)
Q1 2024
Avg closing price
$31.16
Price range
$23.46
-
$45.07
Increased shares by 6.9% (+610 Thousand shares)
Q4 2023
Avg closing price
$24.84
Price range
$17.69
-
$30.76
Increased shares by 4.8% (+401 Thousand shares)
Q3 2023
Avg closing price
$26.81
Price range
$23.01
-
$32.46
Sold 2.2% shares (-191 Thousand shares)
Q2 2023
Avg closing price
$32.45
Price range
$29.32
-
$35.99
Increased shares by 4.4% (+360 Thousand shares)
Q1 2023
Avg closing price
$39.47
Price range
$30.15
-
$48.79
Sold 3.3% shares (-278 Thousand shares)
Q4 2022
Avg closing price
$44.79
Price range
$36.73
-
$51.60
Sold 3.4% shares (-301 Thousand shares)
Q3 2022
Avg closing price
$57.05
Price range
$39.79
-
$70.31
Increased shares by 7.2% (+591 Thousand shares)
Q2 2022
Avg closing price
$39.75
Price range
$29.86
-
$62.36
Increased shares by 2.7% (+217 Thousand shares)
Q1 2022
Avg closing price
$65.59
Price range
$53.73
-
$82.16
Increased shares by 16.7% (+1.14 Million shares)
Q4 2021
Avg closing price
$85.62
Price range
$68.02
-
$99.06
Increased shares by 5.9% (+380 Thousand shares)
Q3 2021
Avg closing price
$100.46
Price range
$84.37
-
$133.60
Increased shares by 35.2% (+1.68 Million shares)
Q2 2021
Avg closing price
$79.68
Price range
$64.12
-
$128.71
Increased shares by 322.3% (+3.65 Million shares)
Q1 2021
Avg closing price
$95.13
Price range
$71.28
-
$120.75
New holding (+1.13 Million shares)
Q4 2020
Avg closing price
$49.18
Price range
$22.24
-
$95.63
